Monica Gandhi, MD, MPH
Biography
Dr. Gandhi has been at UCSF since 1996 when she came here for her medical residency after attending Harvard Medical School. She completed an ID fellowship at UCSF from 1999-2003 and a Masters’ in Public Health in Epidemiology/Biostatistics from the University of California, Berkeley in 2001, as well as a Traineeship in AIDS Prevention Studies (TAPS) post-doctoral fellowship. She has been an NIH funded researcher since 2003, first with a K23 award and now with multiple R01 and R21 grants to help run the UCSF Hair Analytical Laboratory (HAL), a laboratory that focuses on objective adherence metrics to HIV treatment and prevention for multiple UCSF-based and global investigators in hair and urine. She served on the Office of AIDS Research Advisory Committee (OARAC) from 2014-2017 and Chair from 2017-2018. She also serves on the ACTG Executive Committee. She has served as the co-director of the CFAR Mentoring Program for the past five years and has a dedicated interest in HIV mentorship and education.
Dr. Gandhi serves as the Medical Director of the Ward 86 HIV Clinic (since January 2014) and won the HIV Medical Association (HIVMA) Clinical Educator Award in 2017 and was awarded the Master Clinician award in the Department of Medicine in 2019. Beyond an interest in adherence metrics and PrEP, Dr. Gandhi has a special interest in HIV and women and sex differences in HIV medicine. She is thrilled to serve in this role to support the HIV/AIDS researcher community across UCSF and our many affiliates. She is especially interested in mentoring early stage investigators, especially those from underrepresented racial/ethnic minorities, from disadvantaged backgrounds, and with disabilities. Monica plans an open door policy with the CFAR community here at UCSF and is excited to serve with you all in continuing to make UCSF an innovative and exciting place to conduct HIV research.
Displaying 276 - 291 of 291
- Ikediobi O, Aouizerat B, Xiao Y, Gandhi M, Gebhardt S, Warnich L. Analysis of pharmacogenetic traits in two distinct South African populations. Hum Genomics. 2011 May; 5(4):265-82.
- Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, Young M, Milam J, Cohen MH, Sharp GB, Huang Y, Greenblatt RM. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clin Infect Dis. 2011 May; 52(10):1267-75.
- Chandy S, Singh G, Heylen E, Gandhi M, Ekstrand ML. Treatment switching in South Indian patients on HAART: what are the predictors and consequences? AIDS Care. 2011 May; 23(5):569-77.
- Weiser SD, Frongillo EA, Ragland K, Hogg RS, Riley ED, Bangsberg DR. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med. 2009 Jan; 24(1):14-20.
- Brady CJ, Keay L, Villanti A, Ali FS, Gandhi M, Massof RW, Friedman DS. Validation of a visual function and quality of life instrument in an urban Indian population with uncorrected refractive error using Rasch analysis. Ophthalmic Epidemiol. 2010 Oct; 17(5):282-91.
- Yong Huang, Monica Gandhi, Ruth M. Greenblatt, Winnie Gee, Emil T. Lin, Nicholas Messenkoff. Erratum: Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 2010 Apr 15; 24(7):1112-1112.
- Gandhi M and Jacobs RA. . Septic Arthritis and Disseminated Gonococcal Infection (chapter). In Current Rheumatology: Diagnosis and Treatment. 2006.
- Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, Greenblatt RM. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. AIDS. 2005 Nov 04; 19(16):1885-96.
- Liu C, Yang Y, Gange SJ, Weber K, Sharp GB, Wilson TE, Levine A, Robison E, Goparaju L, Gandhi M, Ganhdi M, Merenstein D. Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. AIDS Patient Care STDS. 2009 Nov; 23(11):965-71.
- Gandhi M, Koelle D, Ameli N, Bacchetti P, Greenspan J, Navazesh M, Anastos K, Greenblatt RM . Journal of Dental Research. Salivary shedding of human herpesvirus-8 among HIV-infected women is more frequent at higher CD4 cell counts. 2004; 3(83):639-643.
- Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004; 44:499-523.
- Hessol N, Gandhi M, and RM Greenblatt. . Epidemiology and Natural History of HIV Infection in Women (chapter). In A Guide to the Clinical Care of Women with HIV, Health Resources and Administrations Services (HRSA). 2003.
- Gandhi M and RM Greenblatt. . Human Herpesvirus 8, Kaposi’s Sarcoma, and Associated Conditions (Review). Clinics in Laboratory Medicine. 2002; 883-910 .
- Gandhi M, Greenblatt RM. Human herpesvirus 8, Kaposi's sarcoma, and associated conditions. Clin Lab Med. 2002 Dec; 22(4):883-910.
- Gandhi M, Greenblatt RM. Hair it is: the long and short of monitoring antiretroviral treatment. Ann Intern Med. 2002 Oct 15; 137(8):696-7.
- Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis. 2002 Aug 01; 35(3):313-22.
- Presented at: Special Grant Writing Seminar with Dr. Monica Gandhi:
- Presented at: Special Grant Writing Seminar with Dr. Monica Gandhi:-